Literature DB >> 8088924

Formation and mineralization of extracellular matrix secreted by an immortal human osteoblastic cell line: modulation by tumor necrosis factor-alpha.

F S Panagakos1, L P Hinojosa, S Kumar.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha), a 17-kDa cytokine produced by stimulated macrophages/monocytes, modulates the functions of a variety of cells and has been shown to induce bone resorption in vitro. However, the effects that TNF-alpha may have on the process of bone formation are not completely understood. In order to study the effects of TNF-alpha on matrix development and mineralization, we utilized a human osteoblastic cell line, HOS TE85. Our results show that HOS TE85, which has been shown to be responsive to hormones active on normal osteoblasts, forms an extensive extracellular matrix (ECM) that mineralizes during extended culture. Treatment during the development of the matrix with TNF-alpha has little effect on cell number and DNA synthesis, showing thereby that TNF-alpha is not cytotoxic to the cells. However, TNF-alpha inhibits the formation of alkaline phosphatase (AP)-positive foci in a dose-dependent manner at concentrations of 0.1-10 ng/ml. TNF-alpha treatment caused a significant decrease in the incorporation of collagen into the developing matrix. In addition, TNF-alpha treatment resulted in a significant decrease in the synthesis of AP by HOS TE85 cells during the process of ECM formation and resulted in a pronounced lack of mineralization of the ECM. These results indicate that TNF-alpha may be acting as an uncoupler by decreasing the synthesis and incorporation of proteins required for bone formation, and inhibiting matrix formation and mineralization in vitro.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8088924     DOI: 10.1007/bf01534268

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  28 in total

1.  The fluorometric measurement of deoxyribonucleic acid in animal tissues with special reference to the central nervous system.

Authors:  J M KISSANE; E ROBINS
Journal:  J Biol Chem       Date:  1958-07       Impact factor: 5.157

2.  IL-6 is produced by osteoblasts and induces bone resorption.

Authors:  Y Ishimi; C Miyaura; C H Jin; T Akatsu; E Abe; Y Nakamura; A Yamaguchi; S Yoshiki; T Matsuda; T Hirano
Journal:  J Immunol       Date:  1990-11-15       Impact factor: 5.422

3.  Effect of immune cytokines on bone.

Authors:  P Stashenko; M S Obernesser; F E Dewhirst
Journal:  Immunol Invest       Date:  1989 Jan-May       Impact factor: 3.657

4.  Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro.

Authors:  J Pfeilschifter; C Chenu; A Bird; G R Mundy; G D Roodman
Journal:  J Bone Miner Res       Date:  1989-02       Impact factor: 6.741

5.  Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins.

Authors:  B Peterkofsky; R Diegelmann
Journal:  Biochemistry       Date:  1971-03-16       Impact factor: 3.162

6.  Differentiation of osteoblasts and formation of mineralized bone in vitro.

Authors:  H C Tenenbaum; J N Heersche
Journal:  Calcif Tissue Int       Date:  1982-01       Impact factor: 4.333

7.  Gingival fibroblasts degrade type I collagen films when stimulated with tumor necrosis factor and interleukin 1: evidence that breakdown is mediated by metalloproteinases.

Authors:  M C Meikle; S J Atkinson; R V Ward; G Murphy; J J Reynolds
Journal:  J Periodontal Res       Date:  1989-05       Impact factor: 4.419

8.  1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption.

Authors:  P M McSheehy; T J Chambers
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

9.  Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone.

Authors:  P M McSheehy; T J Chambers
Journal:  Endocrinology       Date:  1986-02       Impact factor: 4.736

10.  Isolation of bone cell clones with differences in growth, hormone responses, and extracellular matrix production.

Authors:  J E Aubin; J N Heersche; M J Merrilees; J Sodek
Journal:  J Cell Biol       Date:  1982-02       Impact factor: 10.539

View more
  9 in total

Review 1.  Diverse biological functions of extracellular collagen processing enzymes.

Authors:  Philip C Trackman
Journal:  J Cell Biochem       Date:  2005-12-01       Impact factor: 4.429

Review 2.  Bone changes and fracture risk in individuals infected with HIV.

Authors:  Amy H Warriner; Michael J Mugavero
Journal:  Curr Rheumatol Rep       Date:  2010-06       Impact factor: 4.592

3.  Association of -308G/A and -238G/A polymorphisms of TNF-α and osteosarcoma risk.

Authors:  Zhongwei Zhao; Xiangyu Tang; Kai Song; Xiang Li; Yonggang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

Review 4.  Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention.

Authors:  Sougata Karmakar; Jonathan Kay; Ellen M Gravallese
Journal:  Rheum Dis Clin North Am       Date:  2010-05       Impact factor: 2.670

5.  Simultaneous gene expression analysis of steady-state and actively translated mRNA populations from osteosarcoma MG-63 cells in response to IL-1alpha via an open expression analysis platform.

Authors:  Jingfang Ju; Chunli Huang; Stacey A Minskoff; Jane E Mayotte; Bruce E Taillon; Jan F Simons
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

6.  Differentiation of human osteoblastic cells in culture: modulation of proteases by extracellular matrix and tumor necrosis factor-alpha.

Authors:  F S Panagakos; S Kumar
Journal:  Inflammation       Date:  1995-08       Impact factor: 4.092

7.  Ultrastructural analysis of mineralized matrix from human osteoblastic cells: effect of tumor necrosis factor-alpha.

Authors:  F S Panagakos; C Fernandez; S Kumar
Journal:  Mol Cell Biochem       Date:  1996-05-10       Impact factor: 3.396

8.  An Increased Risk of Osteoporosis during Acquired Immunodeficiency Syndrome.

Authors:  N Annapoorna; G Venkateswara Rao; N S Reddy; P Rambabu; K R S Samabasiva Rao
Journal:  Int J Med Sci       Date:  2004-08-05       Impact factor: 3.738

9.  The effect of TNF-α on osteoblasts in metal wear-induced periprosthetic bone loss.

Authors:  Rita Hameister; Christoph H Lohmann; S Thameem Dheen; Gurpal Singh; Charanjit Kaur
Journal:  Bone Joint Res       Date:  2020-11       Impact factor: 5.853

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.